What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Infectious Disease

PUBLISHER: Market Research Future | PRODUCT CODE: 1759485

PUBLISHER: Market Research Future | PRODUCT CODE: 1759485

Global Artesunate Injection Market Research Report Information by Purity, by Application, by End User, by Distribution Channel, by Region Industry Forecast till 2032

PUBLISHED: May 22, 2025

PAGES: 107 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

Global Artesunate Injection Market Research Report Information by Purity (Artesunate 0.99, Artesunate 0.98), by Application (Malaria, Severe Malaria, Cerebral Malaria, Uncomplicated Malaria, Other Applications), by End User (Hospitals, Clinics, Pharmacies, Government Institutions, Non-Governmental Organizations), by Distribution Channel (Direct Sales, Distributors and Wholesalers, Retail Pharmacies, and Online Sales), by Region (North America, Europe, APAC, South America, MEA) Industry Forecast till 2032

Market Analysis

In 2023, the global artesunate injection market reached a valuation of approximately USD 85 million. From 2024 to 2032, the market is anticipated to grow at a modest compound annual growth rate (CAGR) of 0.9%. Key growth factors include the increasing burden of malaria, the rising preference for injectable therapies that offer rapid action, and advancements in manufacturing and distribution systems. In addition, improved awareness and early diagnosis due to global education initiatives have positively influenced treatment rates.

However, several limitations hinder the market's potential. High production and treatment costs, inconsistent availability in various regions, and stringent regulatory approval processes create roadblocks. Complex intellectual property issues and competition from alternative antimalarial drugs also add pressure to market growth.

Despite these restraints, opportunities exist. The rise of telehealth platforms is helping expand access to diagnosis and treatment in remote, malaria-affected regions. Furthermore, increased collaboration between public and private sectors is resulting in greater funding for malaria-related healthcare solutions. The development of regional manufacturing centers is improving supply chain stability, and general progress in healthcare infrastructure is facilitating better access to artesunate injections. Together, these trends are shaping market dynamics and influencing future pricing, accessibility, and overall demand for artesunate therapies.

Industry Segmentation

Depending on the purity type, the global artesunate injection market is divided into Artesunate 0.99 and Artesunate 0.98.

The global artesunate injection market is divided into end user industry, such as hospitals, clinics, pharmacies, government institutions, non-governmental organizations.

The application type of the global market comprises malaria, severe malaria, cerebral malaria, uncomplicated malaria, other applications.

Based on the distribution channel, the global market has been categorized into direct sales, distributors and wholesalers, retail pharmacies, and online sales.

In terms of regions, the global market comprises, Middle East & Africa, Europe, North America, South America, and Asia Pacific.

Regional Perspectives

In North America, increasing global health awareness has contributed to rising demand for artesunate injections, primarily due to the growing number of travelers visiting malaria-endemic countries. Although malaria is not endemic in Canada or the United States, the region has witnessed a rise in imported cases, necessitating access to rapid and effective treatments like artesunate to prevent severe complications.

In Europe, artesunate has gained recognition from the European Medicines Agency (EMA) as a highly effective treatment for severe malaria. Consequently, many countries have incorporated it into their national treatment guidelines. However, regulatory complexities and cost-related challenges still limit its broader use across the continent.

The Asia-Pacific region has seen expanded adoption of artesunate, largely driven by the World Health Organization's (WHO) recommendation endorsing it as the first-line treatment for severe malaria. This has led to its inclusion in official healthcare protocols throughout malaria-prone nations in the region.

In South America, nations within the Amazon Basin, including Peru, Brazil, and Colombia, continue to experience high rates of malaria transmission. Artesunate plays a crucial role in national malaria response programs, especially for severe infections.

Central African countries like the Democratic Republic of the Congo (DRC) face a heavy malaria burden, where artesunate remains an essential component of frontline treatment.

Major Competitors

Cipla, Guilin Pharma, IPCA Laboratories, AMIVAS, Advacare Pharma, Zydus Cadila, Intas Pharmaceutical, Systacare Remedies, Lexicare Pharma, Watran Pharmaceuticals Pvt. Ltd. are the leading companies in the Global Artesunate Injection Market Research.

Product Code: MRFR/HC/38057-HCR

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
- 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
3.6 APPROACHES FOR MARKET END USER ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
- 3.6.2 DATA FORECASTING
- 3.6.3 DATA FORECASTING TECHNIQUE
3.7 DATA MODELING
- 3.7.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.7.2 DATA MODELING:
3.8 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 INCREASING PREVALENCE OF MALARIA
- 4.2.2 GROWING DEMAND FOR INJECTABLE TREATMENTS
- 4.2.3 ADVANCEMENTS IN MANUFACTURING AND DISTRIBUTION
- 4.2.4 GROWING AWARENESS AND EDUCATION
4.3 RESTRAINTS
- 4.3.1 HIGH COST OF ARTESUNATE INJECTIONS
- 4.3.2 LIMITED AVAILABILITY IN CERTAIN REGIONS
- 4.3.3 REGULATORY CHALLENGES AND LENGTHY APPROVAL PROCESSES
- 4.3.4 INTELLECTUAL PROPERTY AND PATENT ISSUES
- 4.3.5 COMPETING ANTIMALARIAL THERAPIES
4.4 OPPORTUNITY
- 4.4.1 EXPANSION OF TELEHEALTH SERVICES FOR REMOTE DIAGNOSIS AND TREATMENT
- 4.4.2 INCREASED PUBLIC-PRIVATE PARTNERSHIPS FOR FUNDING MALARIA RESEARCH
- 4.4.3 DEVELOPMENT OF COMBINATION THERAPIES TO ENHANCE TREATMENT EFFICACY
- 4.4.4 EMERGENCE OF REGIONAL MANUFACTURING HUBS TO BOOST SUPPLY CHAIN RESILIENCE
- 4.4.5 IMPACT ON OVERALL HEALTHCARE SECTOR
- 4.4.6 IMPACT ON GLOBAL ARTESUNATE INJECTION MARKET
- 4.4.7 IMPACT ON THE SUPPLY CHAIN OF THE ARTESUNATE INJECTION MARKET
- 4.4.8 IMPACT ON MARKET DEMAND OF ARTESUNATE INJECTION MARKET
- 4.4.9 IMPACT ON PRICING OF ARTESUNATE INJECTION MARKET

5 MARKET FACTOR ANALYSIS

5.1 SUPPLY CHAIN ANALYSIS
- 5.1.1 RAW MATERIAL SUPPLIERS
- 5.1.2 MANUFACTURING
- 5.1.3 DISTRIBUTION AND LOGISTICS
- 5.1.4 RETAIL AND CONSUMPTION
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 BARGAINING POWER OF SUPPLIERS
- 5.2.2 BARGAINING POWER OF BUYERS
- 5.2.3 THREAT OF NEW ENTRANTS
- 5.2.4 THREAT OF SUBSTITUTES
- 5.2.5 INTENSITY OF RIVALRY

6 GLOBAL ARTESUNATE INJECTION MARKET, BY PURITY

6.1 INTRODUCTION
6.2 ARTESUNATE 0.99
6.3 ARTESUNATE 0.98

7 GLOBAL ARTESUNATE INJECTION MARKET, BY APPLICATION

7.1 INTRODUCTION
- 7.1.1 MALARIA
- 7.1.2 SEVERE MALARIA
- 7.1.3 CEREBRAL MALARIA
- 7.1.4 UNCOMPLICATED MALARIA

8 GLOBAL ARTESUNATE INJECTION MARKET, BY END USER

8.1 INTRODUCTION
- 8.1.1 HOSPITALS
- 8.1.2 CLINICS
- 8.1.3 PHARMACIES
- 8.1.4 GOVERNMENT INSTITUTIONS
- 8.1.5 NON-GOVERNMENTAL ORGANIZATIONS

9 GLOBAL ARTESUNATE INJECTION MARKET, BY DISTRIBUTION CHANNEL

9.1 INTRODUCTION
- 9.1.1 DIRECT SALES
- 9.1.2 DISTRIBUTORS AND WHOLESALERS
- 9.1.3 RETAIL PHARMACIES
- 9.1.4 ONLINE SALES

10 GLOBAL ARTESUNATE INJECTION MARKET, BY REGION

10.1 OVERVIEW
10.2 NORTH AMERICA
10.3 EUROPE
10.4 ASIA PACIFIC
10.5 SOUTH AMERICA
10.6 MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS, 2023
11.3 COMPETITOR DASHBOARD
11.4 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 11.4.1 LAUNCH DEVELOPMENTS

12 COMPANY PROFILES

12.1 AMIVAS
- 12.1.1 COMPANY OVERVIEW
- 12.1.2 TYPES OFFERED
- 12.1.3 SWOT ANALYSIS
- 12.1.4 KEY STRATEGY
12.2 ADVACARE PHARMA
- 12.2.1 COMPANY OVERVIEW
- 12.2.2 TYPES OFFERED
- 12.2.3 SWOT ANALYSIS
- 12.2.4 KEY STRATEGY
12.3 ZYDUS CADILA
- 12.3.1 COMPANY OVERVIEW
- 12.3.2 TYPES OFFERED
- 12.3.3 SWOT ANALYSIS
- 12.3.4 KEY STRATEGY
12.4 INTAS PHARMACEUTICAL
- 12.4.1 COMPANY OVERVIEW
- 12.4.2 TYPES OFFERED
- 12.4.3 SWOT ANALYSIS
- 12.4.4 KEY STRATEGY
12.5 SYSTACARE REMEDIES
- 12.5.1 COMPANY OVERVIEW
- 12.5.2 TYPES OFFERED
- 12.5.3 SWOT ANALYSIS
- 12.5.4 KEY STRATEGY
12.6 LEXICARE PHARMA
- 12.6.1 COMPANY OVERVIEW
- 12.6.2 TYPES OFFERED
- 12.6.3 SWOT ANALYSIS
12.7 CIPLA
- 12.7.1 COMPANY OVERVIEW
- 12.7.2 TYPES OFFERED
- 12.7.3 SWOT ANALYSIS
- 12.7.4 KEY STRATEGY
12.8 GUILIN PHARMA
- 12.8.1 COMPANY OVERVIEW
- 12.8.2 TYPES OFFERED
- 12.8.3 SWOT ANALYSIS
12.9 IPCA LABORATORIES
- 12.9.1 COMPANY OVERVIEW
- 12.9.2 TYPES OFFERED
- 12.9.3 SWOT ANALYSIS
12.10 WATRAN PHARMACEUTICALS PVT. LTD
- 12.10.1 COMPANY OVERVIEW
- 12.10.2 TYPES OFFERED
- 12.10.3 SWOT ANALYSIS

Product Code: MRFR/HC/38057-HCR

LIST OF TABLES

TABLE 1 GLOBAL ARTESUNATE INJECTION MARKET, BY PURITY, 2018-2032 (USD)
TABLE 2 GLOBAL ARTESUNATE INJECTION MARKET, BY APPLICATION, 2018-2032 (USD)
TABLE 3 GLOBAL ARTESUNATE INJECTION MARKET, BY END USER, 2018-2032 (USD)
TABLE 4 GLOBAL ARTESUNATE INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD)
TABLE 5 GLOBAL ARTESUNATE INJECTION MARKET, BY REGION, 2018-2032 (USD)
TABLE 6 NORTH AMERICA: ARTESUNATE INJECTION MARKET, BY COUNTRY, 2018-2032 (USD)
TABLE 7 NORTH AMERICA ARTESUNATE INJECTION MARKET, BY PURITY, 2018-2032 (USD)
TABLE 8 NORTH AMERICA ARTESUNATE INJECTION MARKET, BY APPLICATION, 2018-2032 (USD)
TABLE 9 NORTH AMERICA ARTESUNATE INJECTION MARKET, BY END USER, 2018-2032 (USD)
TABLE 10 NORTH AMERICA ARTESUNATE INJECTION MARKET, DISTRIBUTION CHANNEL, 2018-2032 (USD)
TABLE 11 US ARTESUNATE INJECTION MARKET, BY PURITY, 2018-2032 (USD )
TABLE 12 US: ARTESUNATE INJECTION MARKET, BY APPLICATION, 2018-2032 (USD)
TABLE 13 US ARTESUNATE INJECTION MARKET, BY END USER, 2018-2032 (USD)
TABLE 14 US ARTESUNATE INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD)
TABLE 15 CANADA ARTESUNATE INJECTION MARKET, BY PURITY, 2018-2032 (USD )
TABLE 16 CANADA: ARTESUNATE INJECTION MARKET, BY APPLICATION, 2018-2032 (USD )
TABLE 17 CANADA ARTESUNATE INJECTION MARKET, BY END USER, 2018-2032 (USD )
TABLE 18 CANADA ARTESUNATE INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD )
TABLE 19 EUROPE: ARTESUNATE INJECTION MARKET, BY COUNTRY, 2018-2032 (USD )
TABLE 20 EUROPE ARTESUNATE INJECTION MARKET, BY PURITY, 2018-2032 (USD )
TABLE 21 EUROPE: ARTESUNATE INJECTION MARKET, BY APPLICATION, 2018-2032 (USD )
TABLE 22 EUROPE ARTESUNATE INJECTION MARKET, BY END USER, 2018-2032 (USD )
TABLE 23 EUROPE ARTESUNATE INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD )
TABLE 24 ASIA PACIFIC: ARTESUNATE INJECTION MARKET, BY COUNTRY, 2018-2032 (USD )
TABLE 25 ASIA PACIFIC ARTESUNATE INJECTION MARKET, BY PURITY, 2018-2032 (USD )
TABLE 26 ASIA PACIFIC: ARTESUNATE INJECTION MARKET, BY APPLICATION, 2018-2032 (USD )
TABLE 27 ASIA PACIFIC ARTESUNATE INJECTION MARKET, BY END USER, 2018-2032 (USD )
TABLE 28 ASIA PACIFIC ARTESUNATE INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD )
TABLE 29 SOUTH AMERICA: ARTESUNATE INJECTION MARKET, BY COUNTRY, 2018-2032 (USD )
TABLE 30 SOUTH AMERICA ARTESUNATE INJECTION MARKET, BY PURITY, 2018-2032 (USD )
TABLE 31 SOUTH AMERICA: ARTESUNATE INJECTION MARKET, BY APPLICATION, 2018-2032 (USD )
TABLE 32 SOUTH AMERICA ARTESUNATE INJECTION MARKET, BY END USER, 2018-2032 (USD )
TABLE 33 SOUTH AMERICA ARTESUNATE INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD )
TABLE 34 MIDDLE EAST & AFRICA: ARTESUNATE INJECTION MARKET, BY COUNTRY, 2018-2032 (USD )
TABLE 35 MIDDLE EAST & AFRICA ARTESUNATE INJECTION MARKET, BY PURITY, 2018-2032 (USD )
TABLE 36 MIDDLE EAST & AFRICA: ARTESUNATE INJECTION MARKET, BY APPLICATION, 2018-2032 (USD )
TABLE 37 MIDDLE EAST & AFRICA ARTESUNATE INJECTION MARKET, BY END USER, 2018-2032 (USD )
TABLE 38 MIDDLE EAST & AFRICA ARTESUNATE INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD )
TABLE 39 LAUNCH DEVELOPMENTS
TABLE 40 AMIVAS: PRODUCT OFFERED
TABLE 41 ADVACARE PHARMA: TYPES OFFERED
TABLE 42 ZYDUS CADILA: TYPES OFFERED
TABLE 43 INTAS PHARMACEUTICAL: TYPES OFFERED
TABLE 44 SYSTACARE REMEDIES: TYPES OFFERED
TABLE 45 LEXICARE PHARMA: TYPES OFFERED
TABLE 46 CIPLA: TYPES OFFERED
TABLE 47 GUILIN PHARMA: TYPES OFFERED
TABLE 48 IPCA LABORATORIES: TYPES OFFERED
TABLE 49 WATRAN PHARMACEUTICALS PVT. LTD: TYPES OFFERED

LIST OF FIGURES

FIGURE 1 GLOBAL ARTESUNATE INJECTION MARKET: STRUCTURE
FIGURE 2 GLOBAL ARTESUNATE INJECTION MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
FIGURE 5 SUPPLY CHAIN ANALYSIS: GLOBAL ARTESUNATE INJECTION MARKET
FIGURE 7 PORTER'S FIVE FORCES MODEL: GLOBAL ARTESUNATE INJECTION MARKET
FIGURE 8 GLOBAL ARTESUNATE INJECTION MARKET, BY PURITY, SEGMENT ATTRACTIVENESS ANALYSIS
FIGURE 9 GLOBAL ARTESUNATE INJECTION MARKET, BY PURITY, 2023 (% SHARE)
FIGURE 10 GLOBAL ARTESUNATE INJECTION MARKET, BY APPLICATION, SEGMENT ATTRACTIVENESS ANALYSIS
FIGURE 11 GLOBAL ARTESUNATE INJECTION MARKET, BY APPLICATION, 2023 (% SHARE)
FIGURE 12 GLOBAL ARTESUNATE INJECTION MARKET, BY END USER, SEGMENT ATTRACTIVENESS ANALYSIS
FIGURE 13 GLOBAL ARTESUNATE INJECTION MARKET, BY END USER, 2023 (% SHARE)
FIGURE 14 GLOBAL ARTESUNATE INJECTION MARKET, BY DISTRIBUTION CHANNEL, SEGMENT ATTRACTIVENESS ANALYSIS
FIGURE 15 GLOBAL ARTESUNATE INJECTION MARKET, BY DISTRIBUTION CHANNEL, 2023 (% SHARE)
FIGURE 16 GLOBAL ARTESUNATE INJECTION MARKET, BY REGION, 2023 (% SHARE)
FIGURE 17 NORTH AMERICAN MARKET: SWOT ANALYSIS
FIGURE 18 NORTH AMERICA: ARTESUNATE INJECTION MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 19 EUROPE MARKET: SWOT ANALYSIS
FIGURE 20 EUROPE: ARTESUNATE INJECTION MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 21 ASIA PACIFIC MARKET: SWOT ANALYSIS
FIGURE 22 ASIA PACIFIC: ARTESUNATE INJECTION MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 23 SOUTH AMERICA MARKET: SWOT ANALYSIS
FIGURE 24 SOUTH AMERICA: ARTESUNATE INJECTION MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 25 MIDDLE EAST & AFRICA MARKET: SWOT ANALYSIS
FIGURE 26 MIDDLE EAST & AFRICA: ARTESUNATE INJECTION MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 27 GLOBAL ARTESUNATE INJECTION PLAYERS: COMPETITIVE ANALSIS, 2023
FIGURE 28 COMPETITOR DASHBOARD: GLOBAL ARTESUNATE INJECTION
FIGURE 29 AMIVAS: SWOT ANALYSIS
FIGURE 30 ADVACARE PHARMA: SWOT ANALYSIS
FIGURE 31 ZYDUS CADILA: SWOT ANALYSIS
FIGURE 32 INTAS PHARMACEUTICAL: SWOT ANALYSIS
FIGURE 33 SYSTACARE REMEDIES: SWOT ANALYSIS
FIGURE 34 LEXICARE PHARMA: SWOT ANALYSIS
FIGURE 35 CIPLA: SWOT ANALYSIS
FIGURE 36 GUILIN PHARMA: SWOT ANALYSIS
FIGURE 37 IPCA LABORATORIES: SWOT ANALYSIS
FIGURE 38 WATRAN PHARMACEUTICALS PVT. LTD: SWOT ANALYSIS